Regulation of CMGC kinases by hypoxia

키워드

참고문헌 (70)

1. Druker J, "Role of hypoxia in the control of the cell cycle", Int J Mol Sci, 22, pp.4874~ (2021)
2. Wicks EE, "Hypoxia-inducible factors : cancer progression and clinical translation", J Clin Invest, 132, pp.e159839~ (2022)
3. Semenza GL, "Hypoxia-inducible factors in physiology and medicine", Cell, 148, pp.399~408 (2012)
4. Semenza GL, "HIF-1 and human disease : one highly involved factor", Genes Dev, 14, pp.1983~1991 (2000)
5. Simon MC, "The role of oxygen availability in embryonic development and stem cell function", Nat Rev Mol Cell Biol, 9, pp.285~296 (2008)
6. Semenza GL, "HIF-1 and mechanisms of hypoxia sensing", Curr Opin Cell Biol, 13, pp.167~171 (2001)
7. Wang GL, "Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension", Proc Natl Acad Sci U S A, 92, pp.5510~5514 (1995)
8. Semenza GL, "HIF-1, O(2), and the 3 PHDs : how animal cells signal hypoxia to the nucleus", Cell, 107, pp.1~3 (2001)
9. Sutter CH, "Hypoxiainducible factor 1alpha protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations", Proc Natl Acad Sci U S A, 97, pp.4748~4753 (2000)
10. Maxwell PH, "The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis", Nature, 399, pp.271~275 (1999)
11. Hubbi ME, "Cyclin-dependent kinases regulate lysosomal degradation of hypoxia-inducible factor 1alpha to promote cell-cycle progression", Proc Natl Acad Sci U S A, 111, pp.E3325~E3334 (2014)
12. Lee SB, "An ID2-dependent mechanism for VHL inactivation in cancer", Nature, 529, pp.172~177 (2016)
13. Lee SB, "Proline hydroxylation primes protein kinases for autophosphorylation and activation", Mol Cell, 79, pp.376~389e378 (2020)
14. Manning G, "The protein kinase complement of the human genome", Science, 298, pp.1912~1934 (2002)
15. Aranda S, "DYRK family of protein kinases : evolutionary relationships, biochemical properties, and functional roles", FASEB J, 25, pp.449~462 (2011)
16. Lasorella A, "The ID proteins : master regulators of cancer stem cells and tumour aggressiveness", Nat Rev Cancer, 14, pp.77~91 (2014)
17. Gorres KL, "Prolyl 4-hydroxylase", Crit Rev Biochem Mol Biol, 45, pp.106~124 (2010)
18. Kaelin WG, Jr., "Oxygen sensing by metazoans : the central role of the HIF hydroxylase pathway", Mol Cell, 30, pp.393~402 (2008)
19. Strowitzki MJ, "Protein hydroxylation by hypoxia-inducible factor(HIF)hydroxylases : unique or ubiquitous?", Cells, 8, pp.384~ (2019)
20. Fong GH, "Role and regulation of prolyl hydroxylase domain proteins", Cell Death Differ, 15, pp.635~641 (2008)
21. Zhong H, "Hypoxia-inducible factor 1alpha and 1beta proteins share common signaling pathways in human prostate cancer cells", Biochem Biophys Res Commun, 284, pp.352~356 (2001)
22. Reyes H, "Identification of the Ah receptor nuclear translocator protein(Arnt)as a component of the DNA binding form of the Ah receptor", Science, 256, pp.1193~1195 (1992)
23. Jiang BH, "Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1", J Biol Chem, 271, pp.17771~17778 (1996)
24. Varjosalo M, "The protein interaction landscape of the human CMGC kinase group", Cell Rep, 3, pp.1306~1320 (2013)
25. Chowdhury I, "CMGC kinases in health and cancer", Cancers(Basel), 15, pp.3838~ (2023)
26. Gould CM, "The chaperones Hsp90 and Cdc37 mediate the maturation and stabilization of protein kinase C through a conserved PXXP motif in the C-terminal tail", J Biol Chem, 284, pp.4921~4935 (2009)
27. Lochhead PA, "Protein kinase activation loop autophosphorylation in cis: overcoming a Catch-22 situation", Sci Signal, 2, pp.pe4~ (2009)
28. van der Laden J, "Effect of tyrosine autophosphorylation on catalytic activity and subcellular localisation of homeodomain-interacting protein kinases(HIPK)", Cell Commun Signal, 13, pp.3~ (2015)
29. Asghar U, "The history and future of targeting cyclin-dependent kinases in cancer therapy", Nat Rev Drug Discov, 14, pp.130~146 (2015)
30. Malumbres M, "Cyclin-dependent kinases", Genome Biol, 15, pp.122~ (2014)
31. Lukasik P, "Cyclindependent kinases(CDK)and their role in diseases development-review", Int J Mol Sci, 22, pp.2935~ (2021)
32. Ghafouri-Fard S, "A review on the role of cyclin dependent kinases in cancers", Cancer Cell Int, 22, pp.325~ (2022)
33. Kannan N, "Evolutionary constraints associated with functional specificity of the CMGC protein kinases MAPK, CDK, GSK, SRPK, DYRK, and CK2alpha", Protein Sci, 13, pp.2059~2077 (2004)
34. Lim S, "Cdks, cyclins and CKIs : roles beyond cell cycle regulation", Development, 140, pp.3079~3093 (2013)
35. Ding L, "The roles of cyclindependent kinases in cell-cycle progression and therapeutic strategies in human breast cancer", Int J Mol Sci, 21, pp.1960~ (2020)
36. Garcia-Reyes B, "The emerging role of cyclin-dependent kinases(CDKs)in pancreatic ductal adenocarcinoma", Int J Mol Sci, 19, pp.3219~ (2018)
37. Otto T, "Cell cycle proteins as promising targets in cancer therapy", Nat Rev Cancer, 17, pp.93~115 (2017)
38. Braicu C, "A comprehensive review on MAPK : a promising therapeutic target in cancer", Cancers(Basel), 11, pp.1618~ (2019)
39. Johnson GL, "Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38protein kinases", Science, 298, pp.1911~1912 (2002)
40. Cargnello M, "Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases", Microbiol Mol Biol Rev, 75, pp.50~83 (2011)
41. Burotto M, "The MAPK pathway across different malignancies : a new perspective", Cancer, 120, pp.3446~3456 (2014)
42. Murphy LO, "Molecular interpretation of ERK signal duration by immediate early gene products", Nat Cell Biol, 4, pp.556~564 (2002)
43. Fojtik P, "Both hypoxia-inducible factor 1 and MAPK signaling pathway attenuate PI3K", AKT via suppression of reactive oxygen species in human pluripotent stem cells, 2020, pp.8, 607444~
44. 이경희, "Involvement of MAPK pathway in hypoxia-induced up-regulation of urokinase plasminogen activator receptor in a human prostatic cancer cell line, PC3MLN4", Experimental and Molecular Medicine, 36(1), pp.57~65 (2004), 생화학분자생물학회
45. Sang N, "MAPK signaling up-regulates the activity of hypoxia-inducible factors by its effects on p300", J Biol Chem, 278, pp.14013~14019 (2003)
46. Ren H, "Hypoxia converts the myogenic action of insulin-like growth factors into mitogenic action by differentially regulating multiple signaling pathways", Proc Natl Acad Sci U S A, 107, pp.5857~5862 (2010)
47. Wang Y, "Hypoxia-inducible factor-1alpha and MAPK co-regulate activation of hepatic stellate cells upon hypoxia stimulation", PLoS One, 8, pp.e74051~ (2013)
48. Park EC, "The p38 MAP kinase pathway modulates the hypoxia response and glutamate receptor trafficking in aging neurons", Elife, 5, pp.e12010~ (2016)
49. Flugel D, "Glycogen synthase kinase 3 phosphorylates hypoxia-inducible factor 1alpha and mediates its destabilization in a VHL-independent manner", Mol Cell Biol, 27, pp.3253~3265 (2007)
50. Song M, "Cdc2-like kinases : structure, biological function, and therapeutic targets for diseases", Signal Transduct Target Ther, 8, pp.148~ (2023)
51. Bowler E, "Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cells", BMC Cancer, 18, pp.355~ (2018)
52. Becker W, "Emerging role of DYRK family protein kinases as regulators of protein stability in cell cycle control", Cell Cycle, 11, pp.3389~3394 (2012)
53. Hammerle B, "Transient expression of Mnb", Dyrk1a couples cell cycle exit and differentiation of neuronal precursors by inducing p27KIP1 expression and suppressing NOTCH signaling, 2011, pp.138, 2543~2554
54. Litovchick L, "DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly", Genes Dev, 25, pp.801~813 (2011)
55. Park J, "Dyrk1A phosphorylates p53 and inhibits proliferation of embryonic neuronal cells", J Biol Chem, 285, pp.31895~31906 (2010)
56. Yabut O, "Dyrk1A overexpression inhibits proliferation and induces premature neuronal differentiation of neural progenitor cells", J Neurosci, 30, pp.4004~4014 (2010)
57. Dowjat WK, "Trisomydriven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome", Neurosci Lett, 413, pp.77~81 (2007)
58. Soundararajan M, "Structures of Down syndrome kinases, DYRKs, reveal mechanisms of kinase activation and substrate recognition", Structure, 21, pp.986~996 (2013)
59. Himpel S, "Identification of the autophosphorylation sites and characterization of their effects in the protein kinase DYRK1A", Biochem J, 359, pp.497~505 (2001)
60. Becker W, "Structural and functional characteristics of Dyrk, a novel subfamily of protein kinases with dual specificity", Prog Nucleic Acid Res Mol Biol, 62, pp.1~17 (1999)
61. Mercer SE, "Mirk", Dyrk1B : a multifunctional dual-specificity kinase involved in growth arrest, differentiation, and cell survival, 2006, pp.45, 303~315
62. Cockman ME, "Lack of activity of recombinant HIF prolyl hydroxylases(PHDs)on reported non-HIF substrates", Elife, 8, pp.e46490~ (2019)
63. Epstein AC, "C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation", Cell, 107, pp.43~54 (2001)
64. Zhang H, "Hsp90", p50cdc37 is required for mixed-lineage kinase(MLK)3 signaling, 2004, pp.279, 19457~19463
65. Grammatikakis N, "p50(cdc37)acting in concert with Hsp90 is required for Raf-1 function", Mol Cell Biol, 19, pp.1661~1672 (1999)
66. Papenfuss M, "Differential maturation and chaperone dependence of the paralogous protein kinases DYRK1A and DYRK1B", Sci Rep, 12, pp.2393~ (2022)
67. Walte A, "Mechanism of dual specificity kinase activity of DYRK1A", FEBS J, 280, pp.4495~4511 (2013)
68. Lochhead PA, "Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs", Cell, 121, pp.925~936 (2005)
69. Wang L, "Targeting the HSP90-CDC37-kinase chaperone cycle : a promising therapeutic strategy for cancer", Med Res Rev, 42, pp.156~182 (2022)
70. Wang L, "Targeting Hsp90-Cdc37 : a promising therapeutic strategy by inhibiting Hsp90 chaperone function", Curr Drug Targets, 18, pp.1572~1585 (2017)

관련 논문AI추천